(Hypertension. 1998;31:368.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
Angiotensinases Restrict Locally Generated Angiotensin II to the Blood Vessel Wall
From the Department of Medicine IV, University of Erlangen, Erlangen, Germany, and the Franz-Volhard-Klinik, Humboldt University, Berlin, Germany (D.N.M.).
Correspondence to Karl F. Hilgers, MD, Nephrology Research Laboratory, Loschgestrasse 8, D-91054, Erlangen, Germany. E-mail mfm435{at}rzmail.unierlangen.de
We tested the hypothesis that angiotensinases limit the spillover of locally formed angiotensin II into the circulation. The release of angiotensin peptides from isolated rat hindquarters perfused with an artificial medium was measured by high-performance liquid chromatography and radioimmunoassay. The spontaneous release of angiotensins was increased by the angiotensinase inhibitors phenanthroline (850±195 versus 95±33 fmol of angiotensin I per 30 minutes in controls, P<.05, n=5 each) and amastatin (P<.05, n=5 each). Infusion of renin induced sustained local angiotensin I formation, which was also increased by phenanthroline. Stimulation of local angiotensin formation by renin infusion was compared with infusion of exogenous angiotensin II. Renin caused similar increases of perfusion pressure (11.1±2.2 versus 7.6±1.9 mm Hg after angiotensin II, P>.05) despite lower angiotensin II levels in the venous effluent than during infusion of exogenous angiotensin II (65±2 versus 482±33 fmol/mL, P<.05, n=7 each). Thus, renin must have caused higher angiotensin II tissue levels than indicated by the measurements in the venous effluent. The pressor response to renin was abolished by the type 1 angiotensin II receptor antagonist losartan. We conclude that the major part of locally generated angiotensins is not released into the circulation but degraded by angiotensinases within the tissue compartment.
Key Words: angiotensinase • aminopeptidase • angiotensin • renin • vasculature
Abbreviations: ACE = angiotensin-converting enzyme • Ang I = angiotensin I; (1–10) decapeptide • Ang II = angiotensin II; (1–8) octapeptide • Ang III = angiotensin III; (2–8) heptapeptide • Ang IV = angiotensin IV; (3–8) hexapeptide • Ang-(4–8) = angiotensin (4–8) pentapeptide • Ang-(1–9) = angiotensin (1–9) nonapeptide • Ang-(1–7) = angiotensin (1–7) heptapeptide • HPLC = high-performance liquid chromatography • RIA = radioimmunoassay
This article has been cited by other articles:
 |
|
 |
|
  R. Veelken, E.-M. Vogel, K. Hilgers, K. Amann, A. Hartner, G. Sass, W. Neuhuber, and G. Tiegs Autonomic Renal Denervation Ameliorates Experimental Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1371 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Lavrentyev, A. M. Estes, and K. U. Malik Mechanism of High Glucose Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells Circ. Res., August 31, 2007; 101(5): 455 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hartner, M. Porst, B. Klanke, N. Cordasic, R. Veelken, and K. F. Hilgers Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1778 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Luft Matrix-Assisted Laser Desorption/Ionization, Time of Flight, and Angiotensin II Hypertension, September 1, 2005; 46(3): 479 - 480. [Full Text] [PDF]
|
|
|
|
|
|
V. Jankowski, R. Vanholder, M. van der Giet, L. Henning, M. Tolle, G. Schonfelder, A. Krakow, S. Karadogan, N. Gustavsson, J. Gobom, et al. Detection of Angiotensin II in Supernatants of Stimulated Mononuclear Leukocytes by Matrix-Assisted Laser Desorption Ionization Time-of-Flight/Time-of-Flight Mass Analysis Hypertension, September 1, 2005; 46(3): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Hilgers, R. Veelken, D. N. Muller, H. Kohler, A. Hartner, S. R. Botkin, C. Stumpf, R. E. Schmieder, and R. A. Gomez Renin Uptake by the Endothelium Mediates Vascular Angiotensin Formation Hypertension, August 1, 2001; 38(2): 243 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Saris, M. A. van Dijk, I. Kroon, M. A. D. H. Schalekamp, and A. H. J. Danser Functional Importance of Angiotensin-Converting Enzyme-Dependent In Situ Angiotensin II Generation in the Human Forearm Hypertension, March 1, 2000; 35(3): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Chappell, M. N. Gomez, N. T. Pirro, and C. M. Ferrario Release of Angiotensin-(1-7) From the Rat Hindlimb : Influence of Angiotensin-Converting Enzyme Inhibition Hypertension, January 1, 2000; 35(1): 348 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. MaassenVanDenBrink, R. de Vries, P. R. Saxena, M. A.D.H. Schalekamp, and A.H.J. Danser Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase Cardiovasc Res, November 1, 1999; 44(2): 407 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Muller, K. F. Hilgers, S. Mathews, V. Breu, W. Fischli, R. Uhlmann, and F. C. Luft Effects of Human Prorenin in Rats Transgenic for Human Angiotensinogen Hypertension, January 1, 1999; 33(1): 312 - 317. [Abstract] [Full Text] [PDF]
|
|